NCT04601636

Brief Summary

The purpose of this prospective randomized controlled study is to compare the efficiency in preventing perioperative hypothermia of a continuous active prewarming combined with active intraoperative warming versus passive prewarming plus intraoperative warming for short outpatient surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 20, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 26, 2020

Completed
Same day until next milestone

Study Start

First participant enrolled

October 26, 2020

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2021

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2021

Completed
Last Updated

October 4, 2021

Status Verified

October 1, 2021

Enrollment Period

3 months

First QC Date

October 20, 2020

Last Update Submit

October 1, 2021

Conditions

Keywords

Outpatient SurgeriesShort SurgeriesActive Prewarming

Outcome Measures

Primary Outcomes (1)

  • Temperature at the end of surgery (°Celsius)

    Patient Temperature at the end of surgery

    Measure taken at the end of surgery, before the patient leaves the operating room for the recovery room (below 120 minutes)

Secondary Outcomes (6)

  • Incidence of Hypothermia (presence or absence)

    Intraoperative (time frame when patient is in the operative room - below 120 minutes)

  • Delta Temperature Loss (°Celsius)

    Intraoperative (time frame when patient is in the operative room - below 120 minutes)

  • Shivering incidence (number of episodes)

    Length of Stay in the Recovery Room (maximum 2h)

  • Grade of Shivering (likert scale 0 to 4)

    Length of Stay in the Recovery Room (maximum 2h)

  • Recovery Room Length of Stay (minutes)

    Length of Stay in the Recovery Room (maximum 2h)

  • +1 more secondary outcomes

Study Arms (2)

Active Prewarming group (PW group)

ACTIVE COMPARATOR

Group randomized to receive at least 30 minutes of active prewarming before induction of anesthesia, combined to active warming intraoperatively.

Device: Active Prewarming

Control group (C group)

PLACEBO COMPARATOR

Group randomized to receive the standard care : passive prewarming before induction of anesthesia combined to active warming intraoperatively.

Other: Standard Care

Interventions

Active prewarming with Flex Warming Gown (Bair Paws, 3M) for at least 30 minutes before induction of anesthesia, with active warming intraoperatively with Bair Hugger (3M)

Active Prewarming group (PW group)

Standard care with a passive prewarming (warm cotton blankets) before induction of anesthesia, with active warming intraoperatively with (Bair Hugger, 3M)

Control group (C group)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA Physical Status I to III
  • Elective Outpatient Surgery under General Anesthesia
  • Surgery Length from 30 to 120 minutes (from induction of anesthesia to extubation)

You may not qualify if:

  • Patient refusal or inability to consent
  • Neuraxial (spinal or epidural) anesthesia
  • BMI over 40 (Flex gown limitation)
  • Pregnancy
  • Active infection
  • Systemic disease which impairs thermoregulation (hypothyroidism or hyperthyroidism, adrenal insufficiency, major burns, para / quadriplegia)
  • Medications affecting core body temperature (like levothyroxine)
  • Facial surgery
  • Use of a fluid warmer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CIUSSS de l'Est de l'Ile de Montreal

Montreal, Quebec, H1T2M4, Canada

Location

MeSH Terms

Conditions

Hypothermia

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Body Temperature ChangesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, MD, PhD, DESAR, Chair of Research

Study Record Dates

First Submitted

October 20, 2020

First Posted

October 26, 2020

Study Start

October 26, 2020

Primary Completion

January 31, 2021

Study Completion

May 31, 2021

Last Updated

October 4, 2021

Record last verified: 2021-10

Locations